loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2009_267___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Mehta API

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INTERMEDIATES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 MEHTA API PVT. LTD. Boisar IN (1)

    filter

    01 Erythromycin (1)

    filter

    01 India (1)

    filter

    01 Withdrawn by EDQM Failure to CEP procedure (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    MEHTA API PVT. LTD. Boisar IN

    Contact Supplier
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Erythromycin

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2009-267 - Rev 01
    Withdrawn by EDQM F...
    Chemical
    2019-06-11
    2019-11-14
    179
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2009-267 - Rev 01 of Mehta Api Pvt. Ltd. Boisar In

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2009-267 - Rev 01 of Mehta Api Pvt. Ltd. Boisar In 1

    20

    Mehta Api Pvt. Ltd. Boisar In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM and WHO-GMP.

    They are recognized for Strategic partner for Innovator & Generic API companies for >50 years.

    One of their significant offerings is Erythromycin, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2009-267 - Rev 01

    This Chemical Type CEP, issued on June 11, 2019, remains in force until November 14, 2019, ensuring its reliability within the pharmaceutical industry.

    Substance Number 179 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY